Anna Simonazzi
Overview
Explore the profile of Anna Simonazzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menzella F, Fontana M, Contoli M, Ruggiero P, Galeone C, Capobelli S, et al.
J Asthma Allergy
. 2022 May;
15:505-515.
PMID: 35495876
Purpose: Treatment of severe asthma has made great strides thanks to rapid progress in understanding immune response and inflammatory pathways. This led to the advent of the first biologic for...
2.
Besutti G, Rossi P, Ottone M, Spaggiari L, Canovi S, Monelli F, et al.
Sci Rep
. 2022 Mar;
12(1):4270.
PMID: 35277562
Inflammatory burden is associated with COVID-19 severity and outcomes. Residual computed tomography (CT) lung abnormalities have been reported after COVID-19. The aim was to evaluate the association between inflammatory burden...
3.
Menzella F, Fontana M, Galeone C, Ghidoni G, Capobelli S, Ruggiero P, et al.
Multidiscip Respir Med
. 2021 Nov;
16(1):785.
PMID: 34733505
Background: Biological drugs have been recognized as a breakthrough in the treatment of severe refractory asthma. This retrospective real-life observational study aims to evaluate the effect of add-on benralizumab on...
4.
Menzella F, Fontana M, Galeone C, DAmato M, Canonica G, Ghidoni G, et al.
J Asthma Allergy
. 2021 Aug;
14:1019-1031.
PMID: 34413654
Background: The important progress made on asthma phenotyping encouraged the development of new therapeutic strategies, such as monoclonal antibodies (mAbs) and bronchial thermoplasty (BT). The aim of this study is...
5.
Menzella F, Galeone C, Ghidoni G, Ruggiero P, Capobelli S, Simonazzi A, et al.
Multidiscip Respir Med
. 2021 Jul;
16(1):779.
PMID: 34221399
Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by necrotizing eosinophilic granulomatous inflammation that frequently involves the respiratory tract (90% of cases). Asthma in EGPA is systematically severe and often...
6.
Menzella F, Biava M, Bagnasco D, Galeone C, Simonazzi A, Ruggiero P, et al.
Drugs Context
. 2019 Apr;
8:212580.
PMID: 31024635
Severe refractory asthma is characterized by a higher risk of asthma-related symptoms, morbidities, and exacerbations. This disease also determines much greater healthcare costs and deterioration in health-related quality of life...
7.
Menzella F, Galeone C, Lusuardi M, Simonazzi A, Castagnetti C, Ruggiero P, et al.
Ther Clin Risk Manag
. 2017 Nov;
13:1489-1493.
PMID: 29184413
Severe asthma affects between 5% and 10% of patients with asthma worldwide and requires best standard therapies at maximal doses, but there is a subgroup of patients refractory to all...
8.
Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, et al.
Allergy Asthma Immunol Res
. 2017 May;
9(4):368-372.
PMID: 28497924
Omalizumab is frequently used as add-on treatment to inhaled corticosteroids (ICS) and long-acting β2-agonists in patients with suboptimal control of severe asthma. Patients with severe asthma will typically require chronic...
9.
Menzella F, Facciolongo N, Lusuardi M, Piro R, Formisano D, Castagnetti C, et al.
Respir Care
. 2012 May;
57(12):2067-73.
PMID: 22613356
Background: The aim of the study was to evaluate the adequacy of diagnosis and management of respiratory failure (RF) in COPD. Methods: Retrospective analysis of the hospital discharge forms of...
10.
Menzella F, Facciolongo N, Piro R, Formisano D, Roggeri A, Simonazzi A, et al.
Ther Adv Respir Dis
. 2012 Feb;
6(2):87-95.
PMID: 22323442
Objectives: The aim of this study was to assess the stability of the effectiveness of omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma followed for 4...